Ohio Public Employees Retirement System (OPERS)’s Acceleron Pharma XLRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-29,450
Closed -$5.07M 2024
2021
Q3
$5.07M Sell
29,450
-662
-2% -$86.6K 0.02% 740
2021
Q2
$3.78M Buy
30,112
+2,817
+10% +$355K 0.01% 895
2021
Q1
$3.7M Buy
27,295
+872
+3% +$113K 0.01% 848
2020
Q4
$3.38M Buy
26,423
+5,398
+26% +$633K 0.02% 810
2020
Q3
$2.37M Buy
21,025
+3,510
+20% +$349K 0.01% 808
2020
Q2
$1.67M Buy
+17,515
New +$1.69M 0.01% 982

Ohio Public Employees Retirement System (OPERS)'s XLRN Position: Q4 2021 in Review

Ohio Public Employees Retirement System (OPERS) sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 29,450 shares — an estimated $5.07M sold.

Ohio Public Employees Retirement System (OPERS) first reported a position in XLRN in Q2 2020 and held it in 6 quarters. The position peaked at $5.07M in Q3 2021. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.

  • Ohio Public Employees Retirement System (OPERS) reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
  • Ohio Public Employees Retirement System (OPERS) sold 29,450 Acceleron Pharma shares in Q4 2021, an estimated $5.07M.
  • Ohio Public Employees Retirement System (OPERS) first reported a position in Acceleron Pharma in Q2 2020 and held it in 6 quarters.
  • Ohio Public Employees Retirement System (OPERS)'s Acceleron Pharma position peaked at $5.07M in Q3 2021.
  • 1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.

Based on Ohio Public Employees Retirement System (OPERS)'s 13F filing for Q4 2021, filed 15 Feb 2022.